REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Ambulatory Health Care Services | Diagnostic Imaging Centers
Full name: Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. is a company in Colombia, with a head office in Santa Marta. It operates in the Other Ambulatory Health Care Services sector. It was incorporated on February 07, 2014. From the latest financial highlights, Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. reported a net sales revenue increase of 22.96% in 2023. Its’ total assets recorded a growth of 16.73%. The net profit margin of Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. increased by 2.34% in 2023.

Headquarters
Cl 28 8 90 Edificio Real
Santa Marta; Magdalena;

Contact Details: Purchase the Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. report to view the information.
Incorporation Date:
February 07, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Nacional De Endocrinologia Diabetes E Hipertension S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
22.96%
Total operating revenue
22.96%
Operating profit (EBIT)
33.78%
Net Profit (Loss) for the Period
67.21%
Total assets
16.73%
Total equity
28.35%
Operating Profit Margin (ROS)
1.25%
Net Profit Margin
2.34%
Return on Equity (ROE)
5.51%
Quick Ratio
2.28%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?